As healthcare professionals, we often encounter patients with neurodegenerative disorders, among which Parkinson's disease (PD) is prevalent.
PD is a chronic, progressive disorder, primarily affecting the dopaminergic neurons in the substantia nigra of the brain. The resultant dopamine deficiency leads to motor symptoms such as tremors, rigidity, and bradykinesia.
Patients typically present with asymmetric resting tremor, bradykinesia, and rigidity. Non-motor symptoms like depression, cognitive impairment, and autonomic dysfunction may also be present.
Treatment aims to control symptoms and improve quality of life. Pharmacotherapy, including levodopa and dopamine agonists, is the mainstay. Deep brain stimulation may be considered in advanced cases.
Understanding PD, its pathophysiology, clinical presentation, and management options is crucial for optimal patient care. Ongoing research promises more effective therapeutic strategies in the future.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation